Accessibility Menu
Prestige Consumer Healthcare logo

Prestige Consumer Healthcare(NYSE) PBH

Market Cap$2.43BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)+189%
5 Year-12%
1 Year-22%
1 Month+5%
Premium Feature
Moneyball Superscore
53/100
$51.31
+1.56%
+0.79Today
After hours$51.30-$0.01 (-0.02%)
Prestige Consumer Healthcare last closing stock price
MetricPriceDate
Last closeUSD 51.312026-08-21
Prestige Consumer Healthcare stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.14%USD 51.382026-08-14
1 month+4.67%USD 49.022026-07-22
3 month+6.9%USD 48.002026-05-22
Year to date-16.83%USD 61.692025-12-31
1 year-21.6%USD 65.452025-08-21
3 year-13.34%USD 59.212023-08-22
5 year-11.87%USD 58.222021-08-20
Since inception+189.07%USD 17.752005-02-10

Prestige Consumer Healthcare Financials at a Glance

Market Cap

$2.43BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.10B

Net Income (TTM)

$172.01M

EPS (TTM)

$3.57

P/E Ratio

14.37

Dividend

$0.00

Beta (Volatility)

0.42 (Low)

Price

$51.31

Volume

390,331

Open

$50.48

Previous Close

$51.31

Daily Range

$49.91 - $51.37

52-Week Range

$42.62 - $71.07

Estimated Earnings Date

Nov 5, 2026

PBH: Motley Fool Moneyball Superscore

53

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc. makes health products people use every day. They sell medicines for pain, eye care, and skin issues. These products help families treat common ailments without a prescription.

What Is in the Cabinet?

  • North American Healthcare: Provides brands like Monistat, Clear Eyes, and Dramamine; accounts for 85.1% of revenue.
  • International Healthcare: Distributes products in Australia and other global markets; represents 14.9% of revenue.
  • Established Brands: Features a portfolio including BC/Goody's for pain, Dramamine for motion sickness, and Compound W for wart treatment.
  • Wellness and Sleep: Focuses on products like Breathe Right nasal strips and various sleep aids.

Building the Brand Collection

  • Acquired the OTC Wellness Business, including the Breathe Right brand, on June 12, 2026.
  • Purchased Pillar5 Pharma, an eye care manufacturer, on Dec. 18, 2025.
  • Integrated the new Wellness, Sleep & Other category to house acquired healthcare brands.
  • Invested in manufacturing facilities to increase long-term capacity for sterile eye care products.

Where the Company Stands Out

The company uses a low-cost operating model to manage a portfolio of household healthcare brands. Its strategy involves reviving brands that were previously considered noncore assets by larger pharmaceutical firms.

A Look at the Numbers

  • Total revenues reached $265.7 million for the three months ended June 30, 2026, up 6.5% year over year.
  • Gross profit was $136.2 million for the three months ended June 30, 2026, down 3.0% year over year.
  • Average indebtedness rose to $2.0 billion during the three months ended June 30, 2026.
  • Net cash provided by operating activities was $70.8 million for the three months ended June 30, 2026.
  • Average cost of borrowing rose to 5.1% for the three months ended June 30, 2026.

Evolution of the Business

Prestige has transitioned into a focused consumer healthcare company by acquiring and reviving established household brands. Its efficient distribution network helps it reach consumers through pharmacies, supermarkets, and digital platforms.

AI Generated • Aug 6, 2026

Industry

Pharmaceuticals

Employees

890

CEO

Ronald M. Lombardi, MBA, CPA

Headquarters

Tarrytown, NY 10591, US

PBH Financials

Key Financial Metrics (TTM)

Gross Margin

53.26%

Operating Margin

26.26%

Net Income Margin

15.57%

Return on Equity

9.22%

Return on Capital

10.55%

Return on Assets

3.77%

Earnings Yield

6.96%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.43BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

47.37M

Volume

390.33K

Avg. Volume

621.61K

Financials (TTM)

Gross Profit

$588.49M

Operating Income

$290.17M

EBITDA

$312.70M

Operating Cash Flow

$249.40M

Capital Expenditure

-$14.04M

Free Cash Flow

$235.36M

Cash & ST Invst.

$89.13M

Total Debt

$2.06B

Prestige Consumer Healthcare Performance Analysis

Prestige Consumer Healthcare annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 1,127,725,0003.8%
20242024-03-31USD 1,125,357,000-0.2%
20252025-03-31USD 1,137,762,0001.1%
20262026-03-31USD 1,088,705,000-4.3%
Prestige Consumer Healthcare sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-309.9%
Q32025-12-313.4%
Q42026-03-31-0.6%
Q12026-06-30-5.6%
Prestige Consumer Healthcare annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD -1.65N/A
20242024-03-31USD 4.17N/A
20252025-03-31USD 4.292.7%
20262026-03-31USD 3.91-8.8%
Prestige Consumer Healthcare sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30-9.5%
Q32025-12-3112.8%
Q42026-03-3116.5%
Q12026-06-30-46.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

$265.71M

+6.5%

Gross Profit

$136.19M

+0.8%

Gross Margin

51.25%

N/A

Market Cap

$2.43BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.73M

N/A

Employees

890

N/A

Net Income

$29.18M

-38.5%

EBITDA

$61.24M

-23.1%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

$89.13M

-36.1%

Total Debt

$2.06B

+97.9%

Accounts Receivable

$187.36M

+11.3%

Inventory

$190.22M

+24.2%

Long Term Debt

$2.04B

+97.6%

Short Term Debt

$20.16M

+134.4%

Return on Assets

3.77%

N/A

Return on Invested Capital

6.57%

N/A

Free Cash Flow

$67.09M

-14.2%

Operating Cash Flow

$70.79M

-10.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PRVAPrivia Health Group, Inc.
$21.12-0.38%
ZLABZai Lab Limited
$26.01-0.04%
IRONDisc Medicine, Inc.
$79.81+1.23%
ATECAlphatec Holdings, Inc.
$9.48+2.05%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.77+0.10%
IBITiShares Bitcoin Trust
$43.68+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$10.41+0.06%
MARAMara Holdings
$11.26+0.01%

Questions About PBH

What is the current price of Prestige Consumer Healthcare?

Prestige Consumer Healthcare is trading at $51.31 per share.

What is the 52-week range for Prestige Consumer Healthcare?

Over the past 52 weeks, Prestige Consumer Healthcare has traded between $42.62 and $71.07.

How much debt does Prestige Consumer Healthcare have?

As of the most recent reporting period, Prestige Consumer Healthcare reported total debt of $2.07B.

How much cash does Prestige Consumer Healthcare have on hand?

Prestige Consumer Healthcare reported $89.13M in cash and cash equivalents in its most recent financial results.

What is Prestige Consumer Healthcare’s dividend yield?

Prestige Consumer Healthcare does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.